MedChemComm

1.9k papers and 43.8k indexed citations i.

About

The 1.9k papers published in MedChemComm in the last decades have received a total of 43.8k indexed citations. Papers published in MedChemComm usually cover Molecular Biology (1.1k papers), Organic Chemistry (694 papers) and Oncology (283 papers) specifically the topics of Synthesis and biological activity (219 papers), Click Chemistry and Applications (154 papers) and Computational Drug Discovery Methods (150 papers). The most active scholars publishing in MedChemComm are Frank Lovering, Matthew A. J. Duncton, Sylvie Garneau‐Tsodikova, Michael M. Hann, Matthieu Schapira, Renato Ferreira de Freitas, Kristin Jansen Labby, Camille G. Wermuth, Mark A. T. Blaskovich and Ying‐Wei Yang.

In The Last Decade

Fields of papers published in MedChemComm

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in MedChemComm. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in MedChemComm

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in MedChemComm. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in MedChemComm with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025